Maze Therapeutics, Inc.
MAZE
$7.83
$0.233.03%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -19.50% | -146.46% | 0.00% | 300.48% | -7.39% |
| Total Depreciation and Amortization | -10.53% | -12.64% | 0.00% | -7.58% | -2.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.02% | 13.39% | 0.00% | -26.68% | 156.62% |
| Change in Net Operating Assets | 119.71% | -490.74% | 0.00% | 159.56% | -333.44% |
| Cash from Operations | 3.24% | -138.16% | 0.00% | 394.56% | -3.36% |
| Capital Expenditure | -487.38% | 53.08% | 0.00% | -545.59% | -1,233.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -487.38% | 53.08% | 0.00% | -545.59% | -1,233.33% |
| Total Debt Issued | -- | -100.00% | 0.00% | -24.35% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -72.12% | 1.80% | 0.00% | 1,750.00% | 50.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 75.00% | -2,482.61% | 0.00% | -- | -- |
| Cash from Financing | 3,368.00% | -117.38% | 0.00% | -23.60% | 202,250.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 285.42% | -134.90% | 0.00% | 1,725.16% | 77.51% |